biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Category

Uncategorized
30
Jul

Scope Fluidics subsidiary obtains ISO 13485:2016 certification

30.07.2020
Read More
20
Aug

Scope Fluidics begins preparations for the accelerated registration procedure of the PCR|ONE SARS-CoV-2 panel in the USA

20.08.2020
Read More
07
Sep

EIB lends up to EUR 10 million to Scope Fluidics to develop diagnostics equipment for infectious diseases

07.09.2020
Read More
29
Sep

Scope Fluidics implements mass production of PCR|ONE system which detects bacterial and viral infections in 15 minutes

29.09.2020
Read More
30
Sep

Scope Fluidics intends to enter the Warsaw Stock Exchange regulated market in 2021

30.09.2020
Read More
04
Oct

Scope Fluidics launches a manufacturing line for the Bacteromic system

04.10.2020
Read More
12
Oct

Scope Fluidics launches clinical tests of the PCR|ONE SARS-Cov-2 panel in the clinical environment

12.10.2020
Read More
28
Oct

Prof. Prof. Carl Wittwer – the legendary creator of the PCR technology joins the Scope Fluidics Advisory Committee

28.10.2020
Read More
16
Nov

Scope Fluidics successfully issues shares and secures the financing for its flagship project

16.11.2020
Read More
16
Dec

Scope Fluidics obtains another European patent protecting the BacterOMIC technology

16.12.2020
Read More
1 … 7 8 9 10 11 … 14

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home